Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 198

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

Open access
Zhang, Yan, Chen, Rui, Zhang, DuoDuo, Qi, Shuang, Liu, Yan · 2023 · Biomedicine & Pharmacotherapy

Abstract

Metabolites produced by the host and microbiota play a crucial role in how human bodies develop and remain healthy. Most of these metabolites are produced by microbiota and hosts in the digestive tract. Metabolites in the gut have important roles in energy metabolism, cellular communication, and host immunity, among other physiological activities. Although numerous host metabolites, such as free fatty acids, amino acids, and vitamins, are found in the intestine, metabolites generated by gut microbiota are equally vital for intestinal homeostasis. Furthermore, microbiota in the gut is the sole source of some metabolites, including short-chain fatty acids (SCFAs). Metabolites produced by microbiota, such as neurotransmitters and hormones, may modulate and significantly affect host metabolism. The gut microbiota is becoming recognized as a second endocrine system. A variety of chronic inflammatory disorders have been linked to aberrant host-microbiota interplays, but the precise mechanisms underpinning these disturbances and how they might lead to diseases remain to be fully elucidated. Microbiome-modulated metabolites are promising targets for new drug discovery due to their endocrine function in various complex disorders. In humans, metabolotherapy for the prevention or treatment of various disorders will be possible if we better understand the metabolic preferences of bacteria and the host in specific tissues and organs. Better disease treatments may be possible with the help of novel complementary therapies that target host or bacterial metabolism. The metabolites, their physiological consequences, and functional mechanisms of the host-microbiota interplays will be highlighted, summarized, and discussed in this overview.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2023.114295

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 113 references

Research works printed but not linked: 404

  1. Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821 · DOI · Paper page
  2. Daniel, 2021, Host/microbiota interactions in health and diseases – Time for mucosal microbiology!, Mucosal Immunol., 14, 1006, 10.1038/s41385-021-00383-w · DOI
  3. Chassaing, 2012, Gut microbiota drives metabolic disease in immunologically altered mice, Adv. Immunol., 116, 93, 10.1016/B978-0-12-394300-2.00003-X · DOI
  4. Van Treuren, 2020, Microbial contribution to the human metabolome: implications for health and disease, Annu Rev. Pathol., 15, 345, 10.1146/annurev-pathol-020117-043559 · DOI · Paper page
  5. Neu, 2007, Microbes and the developing gastrointestinal tract, Nutr. Clin. Pract., 22, 174, 10.1177/0115426507022002174 · DOI
  6. Wikoff, 2009, Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites, Proc. Natl. Acad. Sci. USA, 106, 3698, 10.1073/pnas.0812874106 · DOI · Paper page
  7. Wrzosek, 2013, Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent, BMC Biol., 11, 61, 10.1186/1741-7007-11-61 · DOI · Paper page
  8. Cheng, 2022, gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites, Nucleic Acids Res., 50, D795, 10.1093/nar/gkab786 · DOI · Paper page
  9. Faas, 2017, Extracellular ATP and adenosine: the Yin and Yang in immune responses?, Mol. Asp. Med., 55, 9, 10.1016/j.mam.2017.01.002 · DOI · Paper page
  10. Yang, 2021, DisBalance: a platform to automatically build balance-based disease prediction models and discover microbial biomarkers from microbiome data, Brief. Bioinform., 22, 10.1093/bib/bbab094 · DOI
  11. Di Martino, 2013, Polyamines: emerging players in bacteria-host interactions, Int. J. Med. Microbiol.: IJMM, 303, 484, 10.1016/j.ijmm.2013.06.008 · DOI · Paper page
  12. Igarashi, 2010, Characteristics of cellular polyamine transport in prokaryotes and eukaryotes, Plant Physiol. Biochem., 48, 506, 10.1016/j.plaphy.2010.01.017 · DOI · Paper page
  13. Lampropoulou, 2016, Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation, Cell Metab., 24, 158, 10.1016/j.cmet.2016.06.004 · DOI · Paper page
  14. Chen, 2020, Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella, Science, 369, 450, 10.1126/science.aaz1333 · DOI · Paper page
  15. Duncan, 2021, Effect of pH on the antimicrobial activity of the macrophage metabolite itaconate, Microbiology, 167, 10.1099/mic.0.001050 · DOI
  16. Berg, 2002, Inhibition of acetate and propionate assimilation by itaconate via propionyl-CoA carboxylase in isocitrate lyase-negative purple bacterium Rhodospirillum rubrum, FEMS Microbiol. Lett., 216, 49, 10.1111/j.1574-6968.2002.tb11413.x · DOI
  17. Durack, 2019, The gut microbiome: relationships with disease and opportunities for therapy, J. Exp. Med., 216, 20, 10.1084/jem.20180448 · DOI · Paper page
  18. Rawls, 2006, Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection, Cell, 127, 423, 10.1016/j.cell.2006.08.043 · DOI · Paper page
  19. Xu, 2007, Evolution of symbiotic bacteria in the distal human intestine, PLOS Biol., 5, 10.1371/journal.pbio.0050156 · DOI · Paper page
  20. Durmuş, 2015, A review on computational systems biology of pathogen-host interactions, Front. Microbiol., 6, 235
  21. Guven-Maiorov, 2016, Pathogen mimicry of host protein-protein interfaces modulates immunity, Semin. Cell Dev. Biol., 58, 136, 10.1016/j.semcdb.2016.06.004 · DOI
  22. Subramanian, 2015, Network representations of immune system complexity, Wiley Inter. Rev. Syst. Biol. Med., 7, 13, 10.1002/wsbm.1288 · DOI
  23. Finlay, 2006, Anti-immunology: evasion of the host immune system by bacterial and viral pathogens, Cell, 124, 767, 10.1016/j.cell.2006.01.034 · DOI · Paper page
  24. Bhavsar, 2007, Manipulation of host-cell pathways by bacterial pathogens, Nature, 449, 827, 10.1038/nature06247 · DOI · Paper page
  25. Stebbins, 2001, Structural mimicry in bacterial virulence, Nature, 412, 701, 10.1038/35089000 · DOI · Paper page
  26. Sal-Man, 2009, Structural microengineers: pathogenic Escherichia coli redesigns the actin cytoskeleton in host cells, Structure, 17, 15, 10.1016/j.str.2008.12.001 · doi:10.1016/j.str.2008.12.001
  27. Moody, 2010, Human papillomavirus oncoproteins: pathways to transformation, Nat. Rev. Cancer, 10, 550, 10.1038/nrc2886 · DOI · Paper page
  28. Filippova, 2002, The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis, J. Biol. Chem., 277, 21730, 10.1074/jbc.M200113200 · DOI · Paper page
  29. Shirin, 2000, Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1), Infect. Immun., 68, 5321, 10.1128/IAI.68.9.5321-5328.2000 · DOI
  30. Lu, 2017, Metabolite measurement: pitfalls to avoid and practices to follow, Annu. Rev. Biochem., 86, 277, 10.1146/annurev-biochem-061516-044952 · DOI · Paper page
  31. Psychogios, 2011, The human serum metabolome, PLOS One, 6, 10.1371/journal.pone.0016957 · DOI · Paper page
  32. Bhat, 2017, Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals, Nutr. Rev., 75, 374, 10.1093/nutrit/nux001 · DOI · Paper page
  33. Sugiyama, 2017, Comprehensive analysis of polyamine transport and biosynthesis in the dominant human gut bacteria: Potential presence of novel polyamine metabolism and transport genes, Int. J. Biochem. Cell Biol., 93, 52, 10.1016/j.biocel.2017.10.015 · DOI
  34. Postler, 2017, Understanding the holobiont: how microbial metabolites affect human health and shape the immune system, Cell Metab., 26, 110, 10.1016/j.cmet.2017.05.008 · DOI · Paper page
  35. Delzenne, 2000, Dietary fructans modulate polyamine concentration in the cecum of rats, J. Nutr., 130, 2456, 10.1093/jn/130.10.2456 · DOI
  36. Noack, 2000, The human gut bacteria Bacteroides thetaiotaomicron and Fusobacterium varium produce putrescine and spermidine in cecum of pectin-fed gnotobiotic rats, J. Nutr., 130, 1225, 10.1093/jn/130.5.1225 · DOI
  37. Levy, 2016, Metabolites: messengers between the microbiota and the immune system, Genes Dev., 30, 1589, 10.1101/gad.284091.116 · DOI · Paper page
  38. Zheng, 2011, The footprints of gut microbial-mammalian co-metabolism, J. Proteome Res., 10, 5512, 10.1021/pr2007945 · DOI · Paper page
  39. Lin, 2018, Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi, Infect. Immun., 86, 10.1128/IAI.00217-18 · DOI
  40. Feng, 2018, Gut microbiota, short-chain fatty acids, and herbal medicines, Front. Pharmcol., 9, 1354, 10.3389/fphar.2018.01354 · DOI · Paper page
  41. Parker, 2018, Host-microbe interaction in the gastrointestinal tract, Environ. Microbiol., 20, 2337, 10.1111/1462-2920.13926 · DOI
  42. Shibata, 2017, Dietary and microbial metabolites in the regulation of host immunity, Front. Microbiol., 8, 2171, 10.3389/fmicb.2017.02171 · DOI
  43. Smith, 1996, Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism, J. Appl. Bacteriol., 81, 288, 10.1111/j.1365-2672.1996.tb04331.x · DOI · Paper page
  44. Devlin, 2016, Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota, Cell Host Microbe, 20, 709, 10.1016/j.chom.2016.10.021 · DOI · Paper page
  45. Saha, 2016, Human microbial metabolites as a source of new drugs, Drug Discov. Today, 21, 692, 10.1016/j.drudis.2016.02.009 · DOI
  46. Friedman, 2018, Microbes vs. chemistry in the origin of the anaerobic gut lumen, Proc. Natl. Acad. Sci. USA, 115, 4170, 10.1073/pnas.1718635115 · DOI · Paper page
  47. de Vladar, 2012, Amino acid fermentation at the origin of the genetic code, Biol. Direct, 7, 6, 10.1186/1745-6150-7-6 · DOI
  48. Canfield, 2006, Early anaerobic metabolisms, Philos. Trans. R. Soc. Lond. B Biol. Sci., 361, 1819, 10.1098/rstb.2006.1906 · DOI · Paper page
  49. Fischbach, 2011, Eating for two: how metabolism establishes interspecies interactions in the gut, Cell Host Microbe, 10, 336, 10.1016/j.chom.2011.10.002 · DOI · Paper page
  50. Nakamura, 2010, Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease, Annu Rev. Food Sci. Technol., 1, 363, 10.1146/annurev.food.102308.124101 · DOI · Paper page
  51. Flint, 2008, Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis, Nat. Rev. Microbiol., 6, 121, 10.1038/nrmicro1817 · DOI · Paper page
  52. Wang, 2018, Metabolite sensing and signaling in cell metabolism, Signal Transduct. Target. Ther., 3, 30, 10.1038/s41392-018-0024-7 · DOI · Paper page
  53. Husted, 2017, GPCR-mediated signaling of metabolites, Cell Metab., 25, 777, 10.1016/j.cmet.2017.03.008 · DOI · Paper page
  54. Shimazu, 2013, Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor, Science, 339, 211, 10.1126/science.1227166 · DOI · Paper page
  55. Mazuy, 2015, Nuclear bile acid signaling through the farnesoid X receptor, Cell. Mol. life Sci., 72, 1631, 10.1007/s00018-014-1805-y · DOI
  56. Engelstoft, 2008, A gut feeling for obesity: 7TM sensors on enteroendocrine cells, Cell Metab., 8, 447, 10.1016/j.cmet.2008.11.004 · DOI
  57. Psichas, 2015, Gut chemosensing mechanisms, J. Clin. Investig., 125, 908, 10.1172/JCI76309 · DOI · Paper page
  58. Correa, 2007, Succinate is a paracrine signal for liver damage, J. Hepatol., 47, 262, 10.1016/j.jhep.2007.03.016 · DOI
  59. Engelstoft, 2016, Opposite regulation of ghrelin and glucagon-like peptide-1 by metabolite G-protein-coupled receptors, Trends Endocrinol. Metab., 27, 665, 10.1016/j.tem.2016.07.001 · DOI
  60. Offermanns, 2014, Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors, Annu Rev. Pharmacol. Toxicol., 54, 407, 10.1146/annurev-pharmtox-011613-135945 · DOI · Paper page
  61. C. Tang, K. Ahmed, A. Gille, Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes, 21(2) (2015) 173–177. · DOI · Paper page
  62. Wanders, 2012, Effects of high fat diet on GPR109A and GPR81 gene expression, Biochem. Biophys. Res. Commun., 425, 278, 10.1016/j.bbrc.2012.07.082 · DOI
  63. T. Quesada-López, R. Cereijo, J.V. Turatsinze, A. Planavila, M. Cairó, A. Gavaldà-Navarro, M. Peyrou, R. Moure, R. Iglesias, M. Giralt, The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes, 7, 2016. 13479. · DOI · Paper page
  64. Rosell, 2014, Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice, Am. J. Physiol. Endocrinol. Metab., 306, E945, 10.1152/ajpendo.00473.2013 · DOI · Paper page
  65. Alvarez-Curto, 2016, Metabolism meets immunity: the role of free fatty acid receptors in the immune system, Biochem. Pharmacol., 114, 3, 10.1016/j.bcp.2016.03.017 · DOI · Paper page
  66. Lustri, 2017, Bacterial chat: intestinal metabolites and signals in host-microbiota-pathogen interactions, Infect. Immun., 85, 10.1128/IAI.00476-17 · DOI
  67. Hernandez-Doria, 2013, Nutrient and chemical sensing by intestinal pathogens, Microbes Infect., 15, 759, 10.1016/j.micinf.2013.06.013 · DOI
  68. Nataro, 1998, Diarrheagenic Escherichia coli, Clin. Microbiol. Rev., 11, 142, 10.1128/CMR.11.1.142 · DOI · Paper page
  69. Collins, 2014, Citrobacter rodentium: infection, inflammation and the microbiota, Nat. Rev. Microbiol., 12, 612, 10.1038/nrmicro3315 · DOI · Paper page
  70. Li, 2011, Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation, Cell, 147, 629, 10.1016/j.cell.2011.09.025 · DOI · Paper page
  71. Lustri, 2017, Bacterial chat: intestinal metabolites and signals in host-microbiota-pathogen interactions, Infect. Immun., 85, 10.1128/IAI.00476-17 · DOI
  72. Luethy, 2017, Microbiota-derived short-chain fatty acids modulate expression of Campylobacter jejuni determinants required for commensalism and virulence, MBio, 8, e00407, 10.1128/mBio.00407-17 · DOI
  73. Mirzaei, 2022, Dual role of microbiota-derived short-chain fatty acids on host and pathogen, Biomed. Pharmacother., 145, 10.1016/j.biopha.2021.112352 · DOI · Paper page
  74. Gillis, 2018, Dysbiosis-associated change in host metabolism generates lactate to support Salmonella growth, Cell Host Microbe, 23, 54, 10.1016/j.chom.2017.11.006 · DOI · Paper page
  75. Faber, 2016, Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion, Nature, 534, 697, 10.1038/nature18597 · DOI · Paper page
  76. Spiga, 2017, An oxidative central metabolism enables Salmonella to utilize microbiota-derived succinate, Cell Host Microbe, 22, 291, 10.1016/j.chom.2017.07.018 · DOI · Paper page
  77. Hung, 2013, The intestinal fatty acid propionate inhibits S almonella invasion through the post‐translational control of HilD, Mol. Microbiol., 87, 1045, 10.1111/mmi.12149 · DOI · Paper page
  78. Gonzalez Chavez, 2010, The physiological stimulus for the BarA sensor kinase, J. Bacteriol., 192, 2009, 10.1128/JB.01685-09 · DOI
  79. Lawhon, 2002, Intestinal short‐chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA, Mol. Microbiol., 46, 1451, 10.1046/j.1365-2958.2002.03268.x · DOI · Paper page
  80. Gantois, 2006, Butyrate specifically down-regulates Salmonella pathogenicity island 1 gene expression, Appl. Environ. Microbiol., 72, 946, 10.1128/AEM.72.1.946-949.2006 · DOI · Paper page
  81. Weiss, 2020, Metabolite transporters as regulators of immunity, Metabolites, 10, 10.3390/metabo10100418 · DOI
  82. Hsu, 2019, Metabolite transporters – the gatekeepers for T cell metabolism, Immunometabolism, 1, 10.20900/immunometab20190012 · DOI
  83. O'Neill, 2016, A guide to immunometabolism for immunologists, Nat. Rev. Immunol., 16, 553, 10.1038/nri.2016.70 · DOI · Paper page
  84. Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 · DOI · Paper page
  85. Palsson-McDermott, 2013, The Warburg effect then and now: from cancer to inflammatory diseases, Bioessays, 35, 965, 10.1002/bies.201300084 · DOI · Paper page
  86. Lin, 2015, SLC transporters as therapeutic targets: emerging opportunities, Nat. Rev. Drug Discov., 14, 543, 10.1038/nrd4626 · DOI · Paper page
  87. Perland, 2017, Classification systems of secondary active transporters, Trends Pharmacol. Sci., 38, 305, 10.1016/j.tips.2016.11.008 · DOI · Paper page
  88. Hediger, 2004, The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction, Pflug. Arch., 447, 465, 10.1007/s00424-003-1192-y · DOI · Paper page
  89. Zhang, 2019, The SLC transporter in nutrient and metabolic sensing, regulation, and drug development, J. Mol. Cell Biol., 11, 1, 10.1093/jmcb/mjy052 · DOI · Paper page
  90. Y.P. Wang, J.T. Li, J. Qu, M. Yin, Q.Y. Lei, Metabolite sensing and signaling in cancer, 295(33) (2020) 11938–11946. · DOI
  91. Kalaitzidis, 2017, Amino acid–insensitive mTORC1 regulation enables nutritional stress resilience in hematopoietic stem cells, J. Clin. Investig., 127, 1405, 10.1172/JCI89452 · DOI
  92. Khaleghpour, 1999, Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities, Mol. Cell. Biol., 19, 4302, 10.1128/MCB.19.6.4302 · DOI
  93. Hay, 2004, Upstream and downstream of mTOR, Genes Dev., 18, 1926, 10.1101/gad.1212704 · DOI · Paper page
  94. Rutherford, 2012, Bacterial quorum sensing: its role in virulence and possibilities for its control, Cold Spring Harb. Perspect. Med., 2, 10.1101/cshperspect.a012427 · DOI · Paper page
  95. Engebrecht, 1984, Identification of genes and gene products necessary for bacterial bioluminescence, Proc. Natl. Acad. Sci. USA, 81, 4154, 10.1073/pnas.81.13.4154 · DOI · Paper page
  96. Walters, 2006, AI-3 synthesis is not dependent on luxS in Escherichia coli, J. Bacteriol., 188, 5668, 10.1128/JB.00648-06 · DOI · Paper page
  97. Clarke, 2006, The QseC sensor kinase: a bacterial adrenergic receptor, Proc. Natl. Acad. Sci. USA, 103, 10420, 10.1073/pnas.0604343103 · DOI · Paper page
  98. Reading, 2009, The two-component system QseEF and the membrane protein QseG link adrenergic and stress sensing to bacterial pathogenesis, Proc. Natl. Acad. Sci. USA, 106, 5889, 10.1073/pnas.0811409106 · DOI · Paper page
  99. Deng, 2004, Dissecting virulence: systematic and functional analyses of a pathogenicity island, Proc. Natl. Acad. Sci. USA, 101, 3597, 10.1073/pnas.0400326101 · DOI · Paper page
  100. Calderon Toledo, 2008, Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7, Am. J. Pathol., 173, 1428, 10.2353/ajpath.2008.071218 · DOI
  101. Luzarowski, 2021, Global mapping of protein–metabolite interactions in Saccharomyces cerevisiae reveals that Ser-Leu dipeptide regulates phosphoglycerate kinase activity, Communications, Biology, 4, 181
  102. Link, 2013, Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo, Nat. Biotechnol., 31, 357, 10.1038/nbt.2489 · DOI · Paper page
  103. Chubukov, 2014, Coordination of microbial metabolism, Nat. Rev. Microbiol., 12, 327, 10.1038/nrmicro3238 · DOI · Paper page
  104. Chubukov, 2014, Coordination of microbial metabolism, Nat. Rev. Microbiol., 12, 327, 10.1038/nrmicro3238 · DOI · Paper page
  105. Gerosa, 2011, Regulation and control of metabolic fluxes in microbes, Curr. Opin. Biotechnol., 22, 566, 10.1016/j.copbio.2011.04.016 · DOI
  106. Changeux, 2016, Allosteric modulation as a unifying mechanism for receptor function and regulation, Cell, 166, 1084, 10.1016/j.cell.2016.08.015 · DOI · Paper page
  107. O’Connell, 2012, Dynamic reorganization of metabolic enzymes into intracellular bodies, Annu. Rev. Cell Dev. Biol., 28, 89, 10.1146/annurev-cellbio-101011-155841 · DOI
  108. Veyel, 2017, System-wide detection of protein-small molecule complexes suggests extensive metabolite regulation in plants, Sci. Rep., 7, 10.1038/srep42387 · DOI
  109. Sokolowska, 2019, PROMIS: global analysis of PROtein‐metabolite interactions, Curr. Protoc. Plant Biol., 4, 10.1002/cppb.20101 · DOI
  110. Lindsley, 2006, Whence cometh the allosterome?, Proc. Natl. Acad. Sci. USA, 103, 10533, 10.1073/pnas.0604452103 · DOI
  111. Diether, 2017, Towards detecting regulatory protein-metabolite interactions, Curr. Opin. Microbiol., 39, 16, 10.1016/j.mib.2017.07.006 · DOI
  112. Gallego, 2010, A systematic screen for protein-lipid interactions in Saccharomyces cerevisiae, Mol. Syst. Biol., 6, 430, 10.1038/msb.2010.87 · DOI · Paper page
  113. Niphakis, 2015, A global map of lipid-binding proteins and their ligandability in cells, Cell, 161, 1668, 10.1016/j.cell.2015.05.045 · DOI · Paper page
  114. Li, 2010, Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses, Cell, 143, 639, 10.1016/j.cell.2010.09.048 · DOI · Paper page
  115. Han, 2020, A novel antidiabetic monomers combination alleviates insulin resistance through bacteria-cometabolism-inflammation responses, Front. Microbiol., 11, 10.3389/fmicb.2020.00173 · DOI
  116. Li, 2013, Cometabolism of microbes and host: implications for drug metabolism and drug‐induced toxicity, Clin. Pharmacol. Ther., 94, 574, 10.1038/clpt.2013.157 · DOI
  117. Elliott, 2015, Urinary metabolic signatures of human adiposity, Sci. Transl. Med., 7, 10.1126/scitranslmed.aaa5680 · DOI · Paper page
  118. Segovia, 2015, Maternal supplementation with conjugated linoleic acid in the setting of diet-induced obesity normalises the inflammatory phenotype in mothers and reverses metabolic dysfunction and impaired insulin sensitivity in offspring, J. Nutr. Biochem., 26, 1448, 10.1016/j.jnutbio.2015.07.013 · DOI
  119. Aoki-Yoshida, 2013, Prevention of UVB-induced production of the inflammatory mediator in human keratinocytes by lactic acid derivatives generated from aromatic amino acids, Biosci. Biotechnol. Biochem., 10.1271/bbb.120979 · DOI
  120. Beloborodova, 2012, Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils, J. Biomed. Sci., 19, 1, 10.1186/1423-0127-19-89 · DOI · Paper page
  121. Huang, 2014, Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid, J. Dermatol. Sci., 73, 232, 10.1016/j.jdermsci.2013.10.010 · DOI · Paper page
  122. Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell, 155, 1451, 10.1016/j.cell.2013.11.024 · DOI · Paper page
  123. Abel, 1995, Behavioral effects of isatin on open field activity and immobility in the forced swim test in rats, Physiol. Behav., 57, 611, 10.1016/0031-9384(94)00365-C · DOI
  124. Bhattacharya, 1991, Anxiogenic activity of isatin, a putative biological factor, in rodents, J. Psychopharmacol., 5, 202, 10.1177/026988119100500304 · DOI
  125. C. Philippe, F. Szabo de Edelenyi, Relation between Mood and the Host-Microbiome Co-Metabolite 3-Indoxylsulfate: Results from the Observational Prospective NutriNet-Santé Study, 9(4) (2021). · DOI
  126. Li, 2021, Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype, Microbiome, 9, 139, 10.1186/s40168-021-01086-x · DOI
  127. Williams, 2010, Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease, BMC Gastroenterol., 10, 1, 10.1186/1471-230X-10-108 · DOI
  128. Wu, 2011, p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease, Nephrol. Dial. Transplant., 26, 938, 10.1093/ndt/gfq580 · DOI · Paper page
  129. Li, 2018, Effects of metabolites derived from gut microbiota and hosts on pathogens, Front. Cell. Infect. Microbiol., 8, 314, 10.3389/fcimb.2018.00314 · DOI · Paper page
  130. Donia, 2015, Human microbiota. Small molecules from the human microbiota, Science, 349, 1254766, 10.1126/science.1254766 · DOI · Paper page
  131. Browne, 2017, Transmission of the gut microbiota: spreading of health, Nat. Rev. Microbiol., 15, 531, 10.1038/nrmicro.2017.50 · DOI · Paper page
  132. Hirata, 2017, Gut microbiome, metabolome, and allergic diseases, Allergol. Int., 66, 523, 10.1016/j.alit.2017.06.008 · DOI
  133. Neish, 2009, Microbes in gastrointestinal health and disease, Gastroenterology, 136, 65, 10.1053/j.gastro.2008.10.080 · DOI · Paper page
  134. Schönfeld, 2016, Short- and medium-chain fatty acids in energy metabolism: the cellular perspective, J. Lipid Res., 57, 943, 10.1194/jlr.R067629 · DOI · Paper page
  135. Heiss, 2018, Gut microbiota-dependent modulation of energy metabolism, J. Innate Immun., 10, 163, 10.1159/000481519 · DOI · Paper page
  136. Strifler, 2016, Inhaled methane limits the mitochondrial electron transport chain dysfunction during experimental liver ischemia-reperfusion injury, PLOS One, 11, 10.1371/journal.pone.0146363 · DOI
  137. Beaumont, 2016, Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: the adaptive response, Free Radic. Biol. Med., 93, 155, 10.1016/j.freeradbiomed.2016.01.028 · DOI
  138. Lee, 2020, Revisiting the bacterial phylum composition in metabolic diseases focused on host energy metabolism, Diabetes Metab. J., 44, 658, 10.4093/dmj.2019.0220 · DOI
  139. Onyszkiewicz, 2020, Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system, Exp. Biol. Med., 245, 166, 10.1177/1535370219900898 · DOI
  140. Lundberg, 2018, Metabolic effects of dietary nitrate in health and disease, Cell Metab., 28, 9, 10.1016/j.cmet.2018.06.007 · DOI · Paper page
  141. Martin-Gallausiaux, 2021, SCFA: mechanisms and functional importance in the gut, Proc. Nutr. Soc., 80, 37, 10.1017/S0029665120006916 · DOI · Paper page
  142. Augeron, 1984, Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate, Cancer Res., 44, 3961
  143. Barnard, 1993, Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells, Cell Growth Differ., 4
  144. Kaiko, 2016, The colonic crypt protects stem cells from microbiota-derived metabolites, Cell, 165, 1708, 10.1016/j.cell.2016.05.018 · DOI · Paper page
  145. Csordas, 1996, Butyrate, aspirin and colorectal cancer, Eur. J. Cancer Prev., 221, 10.1097/00008469-199608000-00002 · DOI
  146. Sengupta, 2006, Does butyrate protect from colorectal cancer?, J. Gastroenterol. Hepatol., 21, 209, 10.1111/j.1440-1746.2006.04213.x · DOI · Paper page
  147. Kushkevych, 2020, Recent advances in metabolic pathways of sulfate reduction in intestinal bacteria, Cells, 9, 10.3390/cells9030698 · DOI · Paper page
  148. Siegel, 1973, Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. I. The Escherichia coli hemoflavoprotein: molecular parameters and prosthetic groups, J. Biol. Chem., 248, 251, 10.1016/S0021-9258(19)44469-4 · DOI · Paper page
  149. Guarneros, 1970, Cysteine desulfhydrase activities of Salmonella typhimurium and Escherichia coli, Biochim. Biophys. Acta, 198, 132, 10.1016/0005-2744(70)90041-0 · doi:10.1016/0005-2744(70)90041-0
  150. Peck, 2019, A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia, Proc. Natl. Acad. Sci. USA, 116, 3171, 10.1073/pnas.1815661116 · DOI · Paper page
  151. Flannigan, 2011, Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis, Am. J. Physiol. Gastrointest. Liver Physiol., 301, G188, 10.1152/ajpgi.00105.2011 · DOI
  152. Tofalo, 2019, Polyamines and gut microbiota, Front. Nutr., 6, 16, 10.3389/fnut.2019.00016 · DOI · Paper page
  153. Löser, 1999, Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development, Gut, 44, 12, 10.1136/gut.44.1.12 · DOI · Paper page
  154. Tomasova, 2021, The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health, Nutr. Metab., 18, 72, 10.1186/s12986-021-00598-5 · DOI
  155. De La Cuesta-Zuluaga, 2021, Genomic insights into adaptations of trimethylamine-utilizing methanogens to diverse habitats, including the human gut, mSystems, 6, 10.1128/mSystems.00939-20 · DOI
  156. Jaworska, 2018, An in vivo method for evaluating the gut-blood barrier and liver metabolism of microbiota products, JoVE (J. Vis. Exp. ), 140
  157. Borrel, 2017, Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome, ISME J., 11, 2059, 10.1038/ismej.2017.72 · DOI
  158. Jaworska, 2019, TMA, a forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology, Toxins, 11, 490, 10.3390/toxins11090490 · DOI
  159. Kim, 2014, Gut microbiota-derived short-chain fatty acids, T cells, and inflammation, Immune Netw., 14, 277, 10.4110/in.2014.14.6.277 · DOI · Paper page
  160. Markowiak-Kopeć, 2020, The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome, Nutrients, 12, 1107, 10.3390/nu12041107 · DOI · Paper page
  161. Zheng, 2017, Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor–dependent repression of claudin-2, J. Immunol., 199, 2976, 10.4049/jimmunol.1700105 · DOI · Paper page
  162. Wang, 2012, Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription, Dig. Dis. Sci., 57, 3126, 10.1007/s10620-012-2259-4 · DOI · Paper page
  163. Parada Venegas, 2019, Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases, Frontiers in immunology, 277, 10.3389/fimmu.2019.00277 · DOI · Paper page
  164. Hase, 2002, Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium, Infect. Immun., 70, 953, 10.1128/IAI.70.2.953-963.2002 · DOI · Paper page
  165. Raqib, 2006, Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic, Proc. Natl. Acad. Sci. USA, 103, 9178, 10.1073/pnas.0602888103 · DOI · Paper page
  166. Zhao, 2018, GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3, Mucosal Immunol., 11, 752, 10.1038/mi.2017.118 · DOI · Paper page
  167. Bansal, 2010, The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation, Proc. Natl. Acad. Sci. USA, 107, 228, 10.1073/pnas.0906112107 · DOI · Paper page
  168. Venkatesh, 2014, Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4, Immunity, 41, 296, 10.1016/j.immuni.2014.06.014 · DOI · Paper page
  169. Jennis, 2018, Microbiota‐derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo, Neurogastroenterol. Motil., 30, 10.1111/nmo.13178 · DOI · Paper page
  170. Wlodarska, 2017, Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation, Cell Host Microbe, 22, 25, 10.1016/j.chom.2017.06.007 · DOI · Paper page
  171. Bansal, 2010, The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation, Proc. Natl. Acad. Sci. USA, 107, 228, 10.1073/pnas.0906112107 · DOI · Paper page
  172. Park, 2018, Indole-3-carbinol promotes goblet-cell differentiation regulating Wnt and notch signaling pathways AhR-dependently, Mol. Cells, 41, 290
  173. Sittipo, 2019, Microbial metabolites determine host health and the status of some, Diseases, 20
  174. Ratajczak, 2019, Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs), Acta Biochim. Pol., 66, 1
  175. Rooks, 2016, Gut microbiota, metabolites and host immunity, Nat. Rev. Immunol., 16, 341, 10.1038/nri.2016.42 · DOI · Paper page
  176. Hesterberg, 2018, Role of polyamines in immune cell functions, Med. Sci., 6
  177. Pérez-Cano, 2010, Influence of breast milk polyamines on suckling rat immune system maturation, Dev. Comp. Immunol., 34, 210, 10.1016/j.dci.2009.10.001 · DOI
  178. Minois, 2011, Polyamines in aging and disease, Aging, 3, 716, 10.18632/aging.100361 · DOI · Paper page
  179. Chyan, 1999, Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid, J. Biol. Chem., 274, 21937, 10.1074/jbc.274.31.21937 · DOI · Paper page
  180. Venkatesh, 2014, Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4, Immunity, 41, 296, 10.1016/j.immuni.2014.06.014 · DOI · Paper page
  181. Dodd, 2017, A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites, Nature, 551, 648, 10.1038/nature24661 · DOI · Paper page
  182. B. Lamas, M.L. Richard, V. Leducq, H.P. Pham, CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, 22(6) (2016) 598–605. · DOI · Paper page
  183. Wammers, 2018, Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids, Sci. Rep., 8, 255, 10.1038/s41598-017-18305-x · DOI
  184. Pols, 2017, Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor, PLOS One, 12, 10.1371/journal.pone.0176715 · DOI
  185. Yao, 2022, The role of short-chain fatty acids in immunity, inflammation and metabolism, Crit. Rev. Food Sci. Nutr., 62, 1, 10.1080/10408398.2020.1854675 · DOI · Paper page
  186. Morrison, 2016, Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism, Gut Microbes, 7, 189, 10.1080/19490976.2015.1134082 · DOI · Paper page
  187. Macfarlane, 2013, Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double‐blind, placebo‐controlled crossover study, Aliment. Pharmacol. Ther., 38, 804, 10.1111/apt.12453 · DOI
  188. Swirski, 2013, Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure, Science, 339, 161, 10.1126/science.1230719 · DOI · Paper page
  189. Vinolo, 2011, Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils, J. Nutr. Biochem., 22, 849, 10.1016/j.jnutbio.2010.07.009 · DOI · Paper page
  190. Lian, 2022, The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment, Front. Immunol., 13, 10.3389/fimmu.2022.912279 · DOI
  191. Zhang, 2000, Regulation of macrophage activation and inflammation by spermine: a new chapter in an old story, Crit. Care Med., 28, N60, 10.1097/00003246-200004001-00007 · DOI
  192. Kibe, 2014, Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice, Sci. Rep., 4, 4548, 10.1038/srep04548 · DOI · Paper page
  193. Park, 2021, Regulation of common neurological disorders by gut microbial metabolites, Exp. Mol. Med., 53, 1821, 10.1038/s12276-021-00703-x · DOI
  194. Lee, 2012, Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis, Clin. Exp. Immunol., 170, 66, 10.1111/j.1365-2249.2012.04637.x · DOI
  195. Felts, 2005, Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide, Brain, 128, 1649, 10.1093/brain/awh516 · DOI · Paper page
  196. Visser, 2005, Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease, J. Immunol., 174, 808, 10.4049/jimmunol.174.2.808 · DOI
  197. Nikolaus, 2017, Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases, Gastroenterology, 153, 1504, 10.1053/j.gastro.2017.08.028 · DOI · Paper page
  198. Gupta, 2012, Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity, Inflamm. Bowel Dis., 18, 1214, 10.1002/ibd.21849 · DOI
  199. Lamas, 2016, CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, Nat. Med., 22, 598, 10.1038/nm.4102 · DOI · Paper page
  200. Goettel, 2016, AHR activation is protective against colitis driven by T cells in humanized mice, Cell Rep., 17, 1318, 10.1016/j.celrep.2016.09.082 · DOI · Paper page

200 of 404 shown

Metadata

Authors
Zhang, Y., Chen, R., Zhang, D., Qi, S., & Liu, Y.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2023-04
Volume
160
Pages
114295
ISSN
0753-3322 (ISSN-L)
OpenAlex
W4318542633
Cited by
198
References
113
FWCI
14.79
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolite interactions between host and microbiota during health and disease: Which feeds the other? https://app.cochat.ai/papers/10.1016/j.biopha.2023.114295
The paper
Zhang, Y., Chen, R., Zhang, D., Qi, S., & Liu, Y. (2023). Metabolite interactions between host and microbiota during health and disease: Which feeds the other? Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2023.114295

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.